focus -WSS

focus

author：Wikipedia 2025-09-27 23:31:52 - browse：34

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How state and local governments are sidelining science

knowledge

WSS

Doctors find melanoma drugs effective against rare brain cancer

How dance can help nurses traumatized by Covid

As digital health tech proliferates, a new institute aims to cut through hype

Why hospitals are withdrawing from US News rankings

Cancer diagnosis changes perspective doctor, former hospital CEO

As digital health tech proliferates, a new institute aims to cut through hype

knowledge

focus

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Startup Neumora takes a novel depression drug to Phase 3

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

First transplant of an entire human eye performed

ChatGPT in medicine: STAT answers readers' burning questions

After decades in use, heart stents finally beat placebo

The cancer drug shortage isn’t new — and neither are the solutions

Study suggests Covid rebound is far more common with Paxlovid than without

In age of alternative facts, a scholarly course on calling out crap

Sanofi seeks simpler, safer CRISPR sickle cell cure

explore

Group opposing PBM reform sets lobbying record

As digital health tech proliferates, a new institute aims to cut through hype

How Medicaid coverage policies for immigrants impact new moms

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Sanofi seeks simpler, safer CRISPR sickle cell cure

At Orexo, a ‘turning point’ for everything but digital health

leisure time

leisure time

knowledge

leisure time